Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2015
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
-
+
WS03 - Early Career & First Time Attendee Session
- 08:00 - 11:30
- 8/06/2022
- Location: Lehar 1
- Not for CME Credit
- Type: Workshop
- Track: N/A
- Moderators:Karen Kelly, Heather Wakelee
-
+
Session Moderator
08:00 - 08:00 | Presenter: Karen Kelly
- Abstract
Loading... -
+
Session Moderator
08:00 - 08:00 | Presenter: Heather Wakelee
- Abstract
Loading... -
+
WS03.01 - Session Introduction
08:00 - 08:01 | Presenter: Karen Kelly
- Abstract
Loading... -
+
WS03.02 - Session Introduction
08:01 - 08:06 | Presenter: Heather Wakelee
- Abstract
Loading... -
+
WS03.03 - Introduction to the IASLC - Why You Should Be a Member
08:06 - 08:21 | Presenter: Karen Kelly
- Abstract
Loading... -
+
WS03.04 - Making the Most of WCLC: A Guide for First Time Attendees
08:21 - 08:36 | Presenter: Jarushka Naidoo
- Abstract
Loading... -
+
WS03.05 - Planning a Career in Lung Cancer - Bench to Bedside and Educational
08:36 - 08:51 | Presenter: Anne-Marie Dingemans
- Abstract
Loading... -
+
WS03.05 - Planning a Career in Lung Cancer - Bench to Bedside and Educational
08:36 - 08:51 | Presenter: Anne-Marie Dingemans
- Abstract
Loading... -
+
WS03.06 - Planning a Career in Lung Cancer - Sponsored and Academic Trials
08:51 - 09:06 | Presenter: Ross Soo
- Abstract
Loading... -
+
WS03.07 - Planning a Career in Lung Cancer - A New Era of Trial Designs
09:06 - 09:21 | Presenter: Simon Ekman
- Abstract
Loading... -
+
WS03.08 - Break
09:21 - 09:51
- Abstract
Loading... -
+
WS03.09 - Principles to Get Your Paper Published
09:51 - 10:06 | Presenter: Alex Adjei
- Abstract
Loading... -
+
WS03.10 - How to Give a Great Presentation
10:06 - 10:21 | Presenter: Pasi A Janne
- Abstract
Loading... -
+
WS03.11 - Role of IASLC in Developing Countries
10:21 - 10:36 | Presenter: Clarissa Mathias
- Abstract
Loading... -
+
WS03.12 - Early Career Researcher Experience
10:36 - 10:51 | Presenter: Alessandro Russo
- Abstract
Loading... -
+
WS03.13 - Live Q&A
10:51 - 11:30
- Abstract
Loading...
-
+
PL01 - Opening Plenary 1: Immunotherapy & Vaccines (Live Streamed Session)
- 18:15 - 19:45
- 8/06/2022
- Location: Hall C1
- Not for CME Credit
- Type: Plenary
- Track: N/A
-
+
Session Moderator
Presenter: Karen Kelly- Abstract
Loading... -
+
PL01.08 - Welcome Address - IASLC CEO
Presenter: Karen Kelly- Abstract
Loading...
-
+
WS08 - Joint IASLC-CSCO-CAALC Session: Liquid Biopsy in Oncogene Driven NSCLC (On-demand)
- 21:00 - 23:59
- 8/06/2022
- Location: On-Demand
- Not for CME Credit
- Type: Workshop
- Track: N/A
- Moderators:Yi-Long Wu, Chunxue Bai, Caicun Zhou, Karen Kelly
-
+
Session Moderator
21:00 - 21:00 | Presenter: Yi-Long Wu
- Abstract
Loading... -
+
Session Moderator
21:00 - 21:00 | Presenter: Chunxue Bai
- Abstract
Loading... -
+
Session Moderator
21:00 - 21:00 | Presenter: Caicun Zhou
- Abstract
Loading... -
+
Session Moderator
21:00 - 21:00 | Presenter: Karen Kelly
- Abstract
Loading... -
+
WS08.01 - Session Introduction
21:00 - 21:02 | Presenter: Yi-Long Wu
- Abstract
Loading... -
+
WS08.02 - Session Introduction
21:02 - 21:04 | Presenter: Chunxue Bai
- Abstract
Loading... -
+
WS08.03 - Session Introduction
21:04 - 21:07 | Presenter: Caicun Zhou
- Abstract
Loading... -
+
WS08.04 - Session Introduction
21:07 - 21:10 | Presenter: Karen Kelly
- Abstract
Loading... -
+
WS08.05 - Minimal Residual Disease (MRD) Negative: Potential for Cure in Resected Oncogene Driven NSCLC? Chinese Perspective
21:10 - 21:30 | Presenter: Jia-Tao Zhang
- Abstract
Loading... -
+
WS08.06 - Could MRD Change Our Clinical Practice? North American Perspective
21:30 - 21:50 | Presenter: Aadel Chaudhuri
- Abstract
Loading... -
+
WS08.07 - How to Use Liquid Biopsy to Monitor Treatment Efficacy for Advanced Driven NSCLC
21:50 - 22:10 | Presenter: Jie Hu
- Abstract
Loading... -
+
WS08.08 - Liquid Biopsy for Advanced Oncogene Driven NSCLC. European Perspective
22:10 - 22:30 | Presenter: Martin Filipits
- Abstract
Loading... -
+
WS08.09 - Sintilimab versus Pembrolizumab as Monotherapy or in Combination with Chemotherapy for Treatment Naïve Metastatic Non-small Cell Lung Cancer
22:30 - 22:40 | Presenter: Si-Yang Maggie Liu
- Abstract
Loading... -
+
WS08.10 - Toripalimab in Combination with CIK Cells in Patients with Advanced NSCLC: An Exploratory Study
22:40 - 22:50 | Presenter: Xuxinyi Ling
- Abstract
Loading... -
+
WS08.11 - Entrectinib in Patients with ROS1 Fusion-Positive (ROS1-fp) NSCLC: Updated Efficacy and Safety Analysis
22:50 - 23:00 | Presenter: Yun Fan
- Abstract
This abstract is currently under embargo and will be released during the conference.
-
+
WS08.12 - Discussant for Oral Abstracts
23:00 - 23:20 | Presenter: Sai-Hong Ignatius Ou
- Abstract
Loading... -
+
WS08.13 - Activity of aPD1-MSLN-CART Cells Against Metastatic Lung Cancer in a Phase 1 Trial
23:20 - 23:21 | Presenter: Xiaorong Dong
- Abstract
Loading... -
+
WS08.14 - Final Analyses of ALTER-L018: A Randomized Phase II Trial of Anlotinib Plus Docetaxel vs Docetaxel as 2nd-line Therapy for EGFR-Negative NSCLC
23:21 - 23:22 | Presenter: Lin Wu
- Abstract
Loading... -
+
WS08.15 - Safety and Efficacy of Sitravatinib + Tislelizumab in Patients with PD-L1+, Locally Advanced/Metastatic, Squamous NSCLC
23:22 - 23:23 | Presenter: Jun Zhao
- Abstract
Loading... -
+
WS08.16 - The Increase of Blood Intratumor Heterogeneity is Associated with Unfavorable Outcomes of ICIs Plus Chemotherapy in NSCLC
23:23 - 23:24 | Presenter: Juan Zhou
- Abstract
Loading... -
+
WS08.17 - Utilization of Tumor Mutational Profiling to Identify the Immunotherapy Response in Non-small Cell Lung Cancer
23:24 - 23:25 | Presenter: Wenbin Li
- Abstract
Loading... -
+
WS08.18 - Discussant for Poster 1 - 5
23:25 - 23:40 | Presenter: Xiaorong Dong
- Abstract
Loading... -
+
WS08.19 - Phase Il Trial of Neoadjuvant Tislelizumab with Chemotherapy for Resectable Stage IIB-III Non-small Cell Lung Cancer
23:40 - 23:41 | Presenter: Yao-Bin Lin
- Abstract
Loading... -
+
WS08.20 - Comprehensive Analysis of a Dendritic Cell Marker Genes Signature to Predict Prognosis and Immunotherapy Response in Lung Adenocarcinoma
23:41 - 23:42 | Presenter: Yuan Li
- Abstract
Loading... -
+
WS08.21 - Immune Evolution of Metastases & Underlying Molecular Mechanisms in Non-small Cell Lung Cancer
23:42 - 23:43 | Presenter: Wen-Fang Tang
- Abstract
Loading... -
+
WS08.22 - Neoadjuvant Toripalimab Combination in Patients with Stage IIB-IIIB NSCLC: A Single-arm, Phase 2 Trial (Renaissance Study)
23:43 - 23:44 | Presenter: Shi Yan
- Abstract
Loading... -
+
WS08.23 - Transcriptomic Heterogeneity in Non-Small Cell Lung Cancer with Four Structure-Based EGFR-Mutation Subgroups
23:44 - 23:45 | Presenter: Shun Lu
- Abstract
Loading... -
+
WS08.24 - Discussant for Poster 6 - 10
23:35 - 23:50 | Presenter: Ming Fang Zhao
- Abstract
Loading...
-
+
EP08.01 - Metastatic Non-small Cell Lung Cancer - Immunotherapy
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
-
+
EP08.01-061 - A Pilot Study of Avelumab and SABR in Non-Responding and Progressing NSCLC Patients Previously Treated with a Checkpoint Inhibitor
Presenter: Megan Eileen Daly- Abstract
Loading...
-
+
P2.12 - Tumor Biology and Biomarkers - Immune Biology & Immunotherapy
- 17:15 - 19:15
- 8/08/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: Regular Poster
- Track: Tumor Biology and Biomarkers - Immune Biology & Immunotherapy
-
+
P2.12-03 - External Validation of a Novel CT-Based Prognostic Radiomic Signature in Patients With Metastatic NSCLC in SWOG S0819 Phase III Randomized Trial
Presenter: Laurent Dercle- Abstract
Loading...
-
+
IBS18 - Women in Thoracic Oncology (In-person Access Only)
- 07:30 - 08:15
- 8/09/2022
- Location: Lehar 4
- IASLC CME Accredited
- Type: Interactive Breakfast Session
- Track: N/A
- Moderators:Francoise Mornex, Silvia Novello, Narjust Florez (Duma)
-
+
IBS18.11 - Panel Discussion - Thriving during a Global Crisis
07:41 - 07:43 | Presenter: Karen Kelly
- Abstract
Loading...
